Page last updated: 2024-12-08
benzoyltyrosine 4-nitroanilide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
benzoyltyrosine 4-nitroanilide: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 188992 |
SCHEMBL ID | 1351202 |
MeSH ID | M0079376 |
Synonyms (17)
Synonym |
---|
btpna |
bz-tyr-pna |
n-benzoyl-l-tyrosine p-nitroanilide |
benzoyltyrosine 4-nitroanilide |
6154-45-6 |
n-[(2s)-3-(4-hydroxyphenyl)-1-(4-nitroanilino)-1-oxopropan-2-yl]benzamide |
(s)-alpha-(benzoylamino)-4-hydroxy-n-(4-nitrophenyl)benzenepropanamide |
benzoyl-l-tyrosine p-nitroanilide |
SCHEMBL1351202 |
(s)-n-(3-(4-hydroxyphenyl)-1-((4-nitrophenyl)amino)-1-oxopropan-2-yl)benzamide |
CJERUMAUMMIPRF-FQEVSTJZSA-N |
n-[1-(4-hydroxybenzyl)-2-(4-nitroanilino)-2-oxoethyl]benzamide # |
benzoyl-l-tyrosine 4-nitroanilide |
mfcd00038109 |
(s)-n-(3-(4-hydroxyphenyl)-1-(4-nitrophenylamino)-1-oxopropan-2-yl)benzamide |
n-[3-(4-hydroxyphenyl)-1-(4-nitroanilino)-1-oxopropan-2-yl]benzenecarboximidic acid |
DTXSID60977108 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.47
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.47) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (16.67%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |